285 related articles for article (PubMed ID: 9844479)
21. [Changing resistance of Pseudomonas aeruginosa isolates from patients with respiratory tract infections].
Nakamori Y
Nihon Rinsho; 1991 Oct; 49(10):2393-8. PubMed ID: 1749095
[No Abstract] [Full Text] [Related]
22. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
[TBL] [Abstract][Full Text] [Related]
23. [Chemical structure , anti-bacterial activity and pharmacokinetics of new quinolones].
Matsumoto F; Nishiwaki K; Morita M
Nihon Rinsho; 1991 Oct; 49(10):2291-8. PubMed ID: 1660945
[No Abstract] [Full Text] [Related]
24. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
25. [Ways of increasing the effectiveness of antibacterial drugs in the treatment of pseudomonas infection in burns].
Moroz AF; Vinogradova OI; Bekbergenov BM; Brodinova NS; Antsiferova NG
Khirurgiia (Mosk); 1976 Jun; (6):81-8. PubMed ID: 827653
[No Abstract] [Full Text] [Related]
26. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
Châtain P
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
[No Abstract] [Full Text] [Related]
27. In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection.
Boutoille D; Jacqueline C; Le Mabecque V; Potel G; Caillon J
Int J Antimicrob Agents; 2009 May; 33(5):417-20. PubMed ID: 19157801
[TBL] [Abstract][Full Text] [Related]
28. Sulphenazone sensitivity of some pathogens, and its effect in diseases of the upper respiratory tract.
Korányi G; Pesti E; Somogyi G
Acta Paediatr Acad Sci Hung; 1972; 13(3):225-30. PubMed ID: 4631517
[No Abstract] [Full Text] [Related]
29. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.
Tacconelli E; Tumbarello M; Bertagnolio S; Citton R; Spanu T; Fadda G; Cauda R
Emerg Infect Dis; 2002 Feb; 8(2):220-1. PubMed ID: 11897080
[No Abstract] [Full Text] [Related]
30. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.
Paul M; Leibovici L
Lancet Infect Dis; 2005 Apr; 5(4):192-3; discussion 193-4. PubMed ID: 15792730
[No Abstract] [Full Text] [Related]
31. [Pyoinflammatory ENT and upper airway diseases: the importance of the problem and approaches to its management].
Kriukov AI; Zhukhovitskiĭ VG
Vestn Otorinolaringol; 2004; (1):3-4. PubMed ID: 15029118
[TBL] [Abstract][Full Text] [Related]
32. Anaerobic infections in children.
Brook I
Adv Pediatr; 2000; 47():395-437. PubMed ID: 10959450
[TBL] [Abstract][Full Text] [Related]
33. [Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].
Torné J; García Flores A; Tomás S; Serrano R
Med Clin (Barc); 1987 Oct; 89(13):572. PubMed ID: 3121961
[No Abstract] [Full Text] [Related]
34. Pseudomonas aeruginosa endocarditis in renal transplant recipients.
Nasim A; Baqi S; Akhtar SF
Transpl Infect Dis; 2012 Apr; 14(2):180-3. PubMed ID: 21883760
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
36. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
[No Abstract] [Full Text] [Related]
37. [Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain].
Bouza E; Garcia-Garrote F; Cercenado E; Marín M; Díaz MS; Sánchez Romero I; Vindel A;
Rev Esp Quimioter; 2003 Mar; 16(1):41-52. PubMed ID: 12750756
[TBL] [Abstract][Full Text] [Related]
38. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
Navas D; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Bugnon D; Potel G
J Antimicrob Chemother; 2004 Oct; 54(4):767-71. PubMed ID: 15317741
[TBL] [Abstract][Full Text] [Related]
39. [In vitro/in vivo discrepancy of antibiotic activity against Pseudomonas aeruginosa].
Gerber AU
Fortschr Med; 1985 Sep; 103(34):807-10. PubMed ID: 3935553
[No Abstract] [Full Text] [Related]
40. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP
Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
